Bloomberg News

Johnson & Johnson’s Synthes Wins $16 Million for Patents (1)

June 16, 2013

Johnson & Johnson’s Synthes Wins $16 Million for Patents

Johnson & Johnson, the world’s largest maker of health-care products, reported $67.2 billion in sales last year. Photographer: Scott Eells/Bloomberg

Johnson & Johnson’s (JNJ:US) DePuy Synthes unit, a maker of artificial spinal repair products, won $16 million in damages from Globus Medical Inc. (GMED:US) when a jury decided that three of its patents were infringed.

A federal jury in Wilmington, Delaware, also decided June 14 after a two-week trial that the DePuy Synthes patents were valid, according to court records.

Globus, based in Audubon, Pennsylvania, was sued by the patent owners in 2011. The trial began June 3 and was overseen by U.S. District Judge Leonard Stark.

Ernie Knewitz, a Johnson & Johnson spokesman, declined to immediately comment on the verdict. Ed Joyce, a Globus spokesman, didn’t immediately return an e-mail today seeking comment on it.

Johnson & Johnson, based in New Brunswick, New Jersey, the world’s largest maker of health-care products, reported $67.2 billion in sales last year. Globus reported $957.2 million in fiscal 2012 sales.

The case is DePuy Synthes v. Globus Medical, 11-cv-00652, U.S. District Court, District of Delaware (Wilmington).

To see the patents in the lawsuit, click: 7,875,076; 7,862,616; and 7,846,207.

To contact the reporter on this story: Phil Milford in Wilmington, Delaware at pmilford@bloomberg.net

To contact the editor responsible for this story: Michael Hytha at mhytha@bloomberg.net


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW

Companies Mentioned

  • JNJ
    (Johnson & Johnson)
    • $104.59 USD
    • 0.31
    • 0.3%
  • GMED
    (Globus Medical Inc)
    • $24.37 USD
    • 0.44
    • 1.81%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus